News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
‘Homing’ radioactive injection shows benefit in prostate cancer trial
A new treatment for advanced prostate cancer that homes in on tumours has shown significant patient benefit in clinical trials, say ICR researchers.
Using cancer epidemiology to understand the causes of the disease
The roots of the modern-day study of cancer risk lie all the way back in the nineteenth century at a nunnery in Italy. It was here in 1842 that a doctor called Rigoni-Stern noticed that nuns virtually never suffered from cervical cancer but had a higher than usual incidence of breast cancer, and wondered whether the explanation might lie in the nuns’ celibacy.
New report pushes for stratified medicine
Read the ICR response to the Academy of Medical Sciences report, which makes recommendations to remove barriers to the development and adoption of stratified medicine.
Measles virus improves radiotherapy treatment
A new combined treatment using the measles virus to target cancer could greatly improve bowel and head & neck cancer treatment, say ICR researchers
New tumour tracker could target moving lung tumours as patients breathe
A new, targeted approach to radiotherapy could improve treatment of lung cancer by tracking a tumour’s movements as patients breathe in and out.
Scientists identify new genetic driver for breast cancer
An over-active gene called GNAS may help drive the growth of some types of difficult-to-treat breast cancers, ICR scientists have found.
Designing precision drugs for children’s cancers
Over the last decade, advances in technology have triggered an explosion in our knowledge about the biology of adult cancers – but we know far less about what causes cancers in children.
High quality of our clinical trials confirmed
The Institute of Cancer Research, London, has successfully retained its status as one of the UK’s specialist centres for designing and running clinical trials.
Clinical trial tests new combination treatment for advanced prostate cancer
Scientists hope to reverse resistance that can develop to the next-generation prostate cancer treatment abiraterone by combining it with a promising experimental treatment, and believe the combination also has potential when given at an earlier stage to prevent resistance developing.
Breast cancer patients with gene fault at increased risk of disease returning
Women with breast cancer who have inherited a damaged version of a gene called CHEK2 are at increased risk of dying from the disease, a major new study reports.
The promise of immunotherapy - and bridging the funding gap
The ICR's Professor Paul Workman, has featured in a BBC Newsnight investigation into promising new cancer treatment approaches including immunotherapy – and the financial stumbling blocks that could stop these advances reaching patients.
New breast cancer test will help women avoid unnecessary chemotherapy
A new genetic test for breast cancer will help identify those women who should be considered for chemo, and those who can avoid it, say ICR researchers.
